Sarcoma Oncology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Pancreatic cancer3 trials
• Colorectal cancer2 trials
• Endometrial cancer1 trial
• Ovarian cancer1 trial
• Sarcoma1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 13 trials

Status

• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• HUYABIO International, LLC.2 trials
• Boundless Bio, Inc.1 trial

Running trials

• Active, not recruiting

  A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

  NCT05485974· Phase 1· HUYABIO International, LLC.· Source

• Active, not recruiting

  A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

  NCT05163028· Phase 1· HUYABIO International, LLC.· Source

Closed trials

• Terminated

  Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

  NCT05827614· Phase 1· Boundless Bio, Inc.· Source